As the medical community develops treatments to combat the coronavirus, another deadly enemy continues to lurk in hospitals across the country: antibiotic-resistant infections.
Infectious Disease Connect may not have a strict focus on the type of novel coronavirus that has plagued the globe recently, but it has seen a lift from the increased attention that infectious diseases have gotten.
MOORESTOWN, N.J., (March 25, 2021) – Tabula Rasa HealthCare, Incâ (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing safe use of medications, has partnered with Infectious Disease (ID) Connect, a leader in infectious diseases telemedicine and antimicrobial stewardship.
Telehealth-Based Infectious Diseases Consulting: One Organization’s Experience As with other specialist medical care, it turns out that infectious diseases medicine lends itself well to telehealth-based consultative services contracted by community hospitals, as a...
PITTSBURGH, Feb. 17, 2021 – Infectious Disease Connect Inc., a UPMC-backed company offering solutions to improve treatment of infectious diseases and antimicrobial stewardship, recently received top scores from KLAS Research, reflecting the quality of its services and high customer satisfaction.